Biomarin Pharmaceutical reported $464.73M in Current Liabilities for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Acadia Pharmaceuticals ACAD:US $ 117.68M 1.92M
Acorda Therapeutics ACOR:US $ 41.12M 4.88M
Agios Pharmaceuticals AGIO:US $ 48.4M 2.6M
Alnylam Pharmaceuticals ALNY:US $ 657.68M 51.72M
Amgen AMGN:US $ 12618M 268M
Bayer BAYN:GR € 33643M 2624M
Biogen BIIB:US $ 5018M 1071.4M
Biomarin Pharmaceutical BMRN:US $ 464.73M 25.69M
Bluebird Bio BLUE:US $ 148.86M 5.97M
Gilead Sciences GILD:US $ 9220M 662M
Insmed INSM:US $ 113.82M 11.43M
Intercept Pharmaceuticals ICPT:US $ 151.43M 0.39M
IONIS PHARMACEUT IONS:US $ 267.81M 39.36M
Moderna Inc MRNA:US 6.81B 2.43B
Neurocrine Biosciences NBIX:US $ 285.7M 32.2M
Ptc Therapeutics PTCT:US $ 567.37M 90.6M
Puma Biotechnology PBYI:US $ 56.83M 17.95M
Regeneron Pharmaceuticals REGN:US $ 3033.9M 26.3M
Sangamo Biosciences SGMO:US $ 119.99M 1.46M
Sarepta Therapeutics SRPT:US $ 545.57M 90.6M
Seattle Genetics SGEN:US $ 608.52M 77.23M
Ultragenyx Pharmaceutical RARE:US $ 220.64M 53.4M
United Therapeutics UTHR:US $ 331.5M 38.9M
Vertex Pharmaceuticals VRTX:US $ 2556.2M 376M
YTE INCY:US $ 926.67M 40.51M